Tag: #Global Trends

Key Development Basel-headquartered generic and biosimilar pharmaceuticals leader Sandoz Group AG has formally entered into definitive settlement agreements totaling approximately... Read more

Key Development U.S. clinical-stage radiopharmaceutical developer Ratio Therapeutics has officially closed a $70 million Series C financing round. The oversubscribed... Read more

Key Development American biotechnology major Amgen Inc. (NASDAQ: AMGN) has formally filed a Form 8-K disclosure with the U.S. Securities... Read more

Key Development American pharmaceutical leader Eli Lilly and Co. (NYSE: LLY) has confirmed the launch of an Expanded Access Program... Read more

Key Development American biotechnology pioneer Moderna, Inc. (NASDAQ: MRNA) officially released its Q2 2026 financial results, exceeding Wall Street consensus... Read more

Key Development Basel-based generics and biosimilars leader Sandoz Group AG has formally entered into definitive settlement agreements to resolve long-standing... Read more

Key Development Following a challenging two-year period marked by profit warnings, executive restructuring, and share price contraction, Novo Nordisk is... Read more

Key Development Sanofi has upgraded its 2026 sales outlook to approximately 10% growth at constant exchange rates, above its previous... Read more

Key Development Healthcare Triangle has completed the issuance of 12,546,540 common shares to satisfy consideration for two previously approved acquisitions,... Read more